New, potentially practice-changing research sheds light on the long-term benefits of estrogen-blocking tamoxifen therapy in women with early-stage breast cancer whose disease is estrogen-receptor positive.

Study signals hope for maintaining sexual function in men undergoing radiation treatment for prostate cancer.

Cancer patients use more blood and platelets than patients with any other illness. Memorial Sloan-Kettering is always in need of blood donations – especially during the holiday season.

Researchers at Memorial Sloan-Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.

A genetic analysis of tumors suggests women are more susceptible than men to the most common form of lung cancer.

Dr. Chi, a physician-scientist and member of the Human Oncology and Pathogenesis Program, studies genetic and epigenetic changes that cause cancer.

Organizers expect this year to be the most successful yet for this national indoor team cycling event, which raises funds for rare cancer research at Memorial Sloan-Kettering.